The lactic acid produced by fermentation lowers the cell pH
to be more acidic and destroys the ability of DNA and RNA to
control cell division. The
lactic acid simultaneously causes severe local pain as it destroys
cell enzymes. Highly alkalinizing
supplements such as Cesium stops tumor pain by countering the lactic
Cesium also directly fights against the cancerous cells by alkalinizing
them. [Read more]
One of the
conditions observed after cesium therapy was a striking rise in blood
uric acid levels. This is caused by massive release of DNA from dead
cancer cells. DNA is metabolized into uric acid. Typically the values
went from 3.5 mg. to 20 mg. This has the potential to cause decreased
kidney function because large amounts of uric acid appearing in kidney
tubules can form crystals that block the tubules. If a large number of
kidney tubules become blocked kidney function fails and uremia appears.
This is easy to prevent by using the pharmaceutical drug Xyloprim (allopurinol) before and
concomitantly with cesium so that excessively high values of uric acid
do not develop. This might only be needed when 20 or more grams of
cesium (high dosage) are being taken daily. Xyloprim lowers the blood level of
uric acid by shifting the metabolism of proteins so that the body
produces less uric acid, thus decreasing the blood levels of uric acid
and the amount of uric acid the kidney needs to excrete.
Ionic Cesium &
Potassium $122. 32 oz. (96 grams) 32 day supply
Clinical Results With Cesium Therapy
Dr. H. E. Sartori began his cesium cancer therapy program in April 1981
at Life Sciences Universal Medical Clinics in Rockville, Md. Fifty
patients with widespread metastatic tumor deposits were treated.
Forty-seven of these 50 patients had already completed maximal
modalities of treatment, i.e. surgery, radiation, multiple courses of
chemotherapy before cesium was tried. Their condition was hopeless.
Cesium chloride was given in 3 equal divided doses of 6 to 9 grams
daily. Supplemental vitamin A emulsion (100,000 to 300,000 U), vitamin
C (4 to 30 grams), zinc (80 to 100 mg., selenium (600 to 1200 mg.), and
amygadalin (1500 mg.) were given plus other supplements. The diet
consisted primarily of whole grains, vegetables, linolenic acid rich
foods (flaxseed, walnut, soy, wheat germ) and other supplemented food.
EDTA (chelation, dimethylsulfoxide (DMSO) and a combination of vitamins
K, and magnesium salts were also given. The types of malignancies
treated included 10 patients with breast cancer, 9 with colon cancer, 6
with prostate cancer, 4 had pancreatic cancer, 5 had lung cancer, 3 had
liver cancer (hepatoma), 3 had lymphoma, 1 had Ewing's sarcoma of the
pelvis, 1 had an adenocarcinoma and 8 had cancer from an unknown site
Approximately 50 % of patients with breast, colon, prostate, pancreas
and lung cancer survived. Three patients were comatose when the therapy
was initiated. Thirteen patients died in the first 2 weeks of therapy.
Autopsy results in each of these 13 disclosed reduction in tumor mass
size caused by cesium therapy. Also pain disappeared in all patients
within 1 to 3 days after initiation of cesium therapy. This may have
reflected decreased production of lactic acid by dying cancer cells.
One breast cancer patient was of considerable interest. She was
comatose when cesium therapy was initiated using a feeding tube. She
received 10 grams of cesium chloride three times daily. She walked out
of the hospital 5 days later. Unfortunately it was not appreciated that
a hip had been completely replaced by tumor tissue which disappeared
with therapy. Having no bony tissue to support her weight she fell at
home fracturing her neck resulting in death. The autopsy revealed no
hip bone and only very small amounts of cancer tissue. This is a
spectacular therapeutic result despite the tragic death.
In a group of 8 patients where the site of origin of the malignancy was
unknown 2 patients died in the first 14 days and 2 more died in the
first year. Four of the patients were still alive when last heard from
more than a year later. Conventional cancer therapy has never produced
any results like these as similar cases without a clear site of origin
for cancer usually die rapidly.
A patient with lymphoma had a huge hard abdomen. He weighed 250 pounds.
120 pounds of weight was lost in the first 3 months of cesium therapy.
His spleen was initially in his pelvis. This shrank to nearly normal
size. The liver was enlarged to the umbilicus before therapy. This
returned to normal size in 3 months. He was alive 3 years later at
which time he was again taking chemotherapy.
Dr. Sartori believes that doses of cesium should not exceed 20 to 40
grams daily because of side effects of nausea and diarrhea. He felt
that these results confirmed earlier results by Messiha which had
suggested that large doses of cesium seemed to be more effective than
Dr. Sartori took 40 grams of cesium himself which caused only nausea
and unusual sensations around the mouth believed to be related to
potassium depletion. The usual dosage used in his clinic was 2 or 3
grams three times daily. When there is no remaining sign of cancer he
thinks the dose can be safely reduced to .5 or 1 gram daily. Some
patients on cesium develop evidence of potassium depletion so serum
potassium needs to be monitored along with uric acid blood levels. Any
alkali therapy changes the ph of the body toward a more alkalotic
state. This causes movement of potassium into cells which may result in
low serum potassium values. This movement of potassium into cells means
that a person can become seriously depleted of potassium even if there
is no diarrhea or vomiting.
A case of primary liver cancer (hepatoma) was treated later. She was a
39 year old school teacher who was terminal on arrival on April 25,
1984. Her liver was enlarged 1 inch below the umbilicus. She walked out
of the hospital on May 10, 1984. Her liver had shrunk to 2 inches above
the umbilicus. The alpha fetoprotein tumor marker for hepatoma had
decreased from 39,000 units to 5000 units.
On one occasion Dr. Sartori noticed the disappearance of metastatic
tumor masses within one hour of cesium therapy. Two days later wrinkles
appeared in the skin where the tumor masses had been located.
Physicist A. Keith Brewer became very interested in cancer in the
1930s. He performed fundamental research on the membranes surrounding
normal cells, rapidly growing cells (embryonal and cancerous) and dead
tissue. The methods used by him included spectrographic, fluorescence
decay patterns, and phosphorescence decay patterns of radioisotopes of
potassium in nature. He felt that he was one of only a few persons who
had actually studied ion transport across membranes.
His research enabled him to devise a protocol to treat cancer patients
using cesium. Dr. Brewer then treated 30 patients with various cancers
using cesium with all subjects surviving. The patients he treated were
obviously not as sick as those in Dr. Sartori's group but his results
provide further very encouraging evidence about cesium's value.
Rescuing 25 cancer victims from certain death is a remarkable
accomplishment for cesium therapy. Conventional therapy for
malignancies using chemotherapy and radiation has never been able to
cure patients whose initial tumor has spread to another site i.e.
liver, lung , brain, etc. The nearly deceased patients treated by Dr.
Sartori had tumor deposits scattered all over their bodies. A sizeable
number (50 %) of these patients recovered. Additionally, it is unheard
of for a patient whose site of origin of a tumor remains unknown to
recover. In Dr. Sartori's series 4 out of 8 such patients were alive
one year later.